Table 3

sICH and bleeding events of patients

OutcomeAspirin, n (%)DAPT, n (%)Intravenous t-PA, n (%)
sICH (per ECASS II)8 (2.1)
Bleeding (GUSTO)
 Serious1 (0.4)0 (0.0)
 Moderate1 (0.4)0 (0.0)
Minor0 (0.0)2 (0.9)
Any bleeding2 (0.9)1 (0.5)
  • DAPT, dual antiplatelet therapy; ECASS II, European Co-operative Acute Stroke Study-II; GUSTO, Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries; sICH, symptomatic intracranial haemorrhage; t-PA, recombinant tissue plasminogen activator.